[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Summit Therapeutics Inc. Common Stock (SMMT) Summit Therapeutics shares are up amid reports of a potential $15B licensing deal with AstraZeneca. Ivonescimab data disappoints in Western patients, causing concern. ### About Summit Therapeutics Inc. Common Stock Summit Therapeutics Inc. Common Stock (SMMT) is a biopharmaceutical company. Summit Therapeutics Inc. Common Stock uses the ticker $SMMT for trading. Listed in the [Stocks](/list/stocks) and category. ### Insights [#](/topic/$smmt/insights) - Summit Therapeutics Inc. Common Stock (SMMT) market dominance near a 52-week low at XXXXX. - Summit Therapeutics Inc. Common Stock (SMMT) creators hit XXX which is XXX% higher than it's daily average. - Summit Therapeutics Inc. Common Stock (SMMT) trading volume is up XXXXX% from the previous week. - Summit Therapeutics Inc. Common Stock (SMMT) social dominance is up XXXXXXXX% from the previous week. - Summit Therapeutics Inc. Common Stock (SMMT) galaxy scoreβ’ is up XXXXXX% from the previous month. - Summit Therapeutics Inc. Common Stock (SMMT) engagements is up XXXXXX% from the previous week. - Summit Therapeutics Inc. Common Stock (SMMT) posts created is up XXXXXXXX% from the previous week. ### Price: $XXXXX [#](/topic/$smmt/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/close.tsv) The XXXX% price increase appears to be driven by positive market sentiment, hype from top creators, the anticipation of Phase X data, and a potential deal with AstraZeneca, fueled by rumors of a $XX billion partnership and increased social engagement. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | -XXXX% | -XXXX% | XXXX% | **1-Year High**: $XXXXX on 2025-04-24 **1-Year Low**: $XXXXX on 2025-04-08 ### AltRank: XXX [#](/topic/$smmt/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/alt_rank.tsv) Summit Therapeutics Inc. Common Stock (SMMT) is currently AltRank #196 based on combined combined social and market metrics **Daily Average**: XXX **1 Week**: XXX -XXX **1 Month**: XXX -XXX **6 Months**: XXX +155 **1 Year**: XXX -XX **1-Year High**: XXXXX on 2025-08-11 **1-Year Low**: X on 2025-02-09 ### Galaxy Score: XXXXX [#](/topic/$smmt/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX +28 **1 Month**: XX +31 **6 Months**: XX -XX **1 Year**: XX +4 **1-Year High**: XX on 2025-04-22 **1-Year Low**: X on 2025-03-18 ### Engagements: XXXXXXX [#](/topic/$smmt/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/interactions.tsv) **Current Value**: XXXXXXX **Daily Average**: XXXXXX **1 Week**: XXXXXXX +247% **1 Month**: XXXXXXX -XX% **6 Months**: XXXXXXXXX +18% **1 Year**: XXXXXXXXX -XX% **1-Year High**: XXXXXXX on 2025-04-25 **1-Year Low**: XXX on 2025-09-20 | Social Network | X | Reddit | YouTube | | -------------- | - | ------ | ------- | | Engagements | XXXXXXX | XX | X | ### Mentions: XXX [#](/topic/$smmt/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/posts_active.tsv) **Current Value**: XXX **Daily Average**: XXX **1 Month**: XXX -XX% **6 Months**: XXXXX -XXXX% **1 Year**: XXXXXX +61% **1-Year High**: XXX on 2025-07-18 **1-Year Low**: XX on 2025-10-07 | Social Network | X | Reddit | YouTube | | -------------- | - | ------ | ------- | | Mentions | XXX | X | X | ### Creators: XXX [#](/topic/$smmt/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/contributors_active.tsv) XXX unique social accounts have posts mentioning Summit Therapeutics Inc. Common Stock (SMMT) in the last XX hours which is up XXX% from XX in the previous XX hours **Daily Average**: XXX **1 Month**: XXX -XX% **6 Months**: XXXXX +34% **1 Year**: XXXXX +105% **1-Year High**: XXX on 2025-07-18 **1-Year Low**: XX on 2025-10-07 The most influential creators that mention Summit Therapeutics Inc. Common Stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@Biotech2k1](/creator/twitter/Biotech2k1) | X | XXXXXX | X | XXXXXX | | [@semodough](/creator/twitter/semodough) | X | XXXXXX | X | XXXXXX | | [@Banana_Oncology](/creator/twitter/Banana_Oncology) | X | XXXXX | X | XXXXXX | | [@doepke_michel](/creator/twitter/doepke_michel) | X | XXXXX | X | XXXXX | | [@JacobPlieth](/creator/twitter/JacobPlieth) | X | XXXXXX | X | XXXXX | | [@earnings_guy](/creator/twitter/earnings_guy) | X | XXXXXX | X | XXXXX | | [@planert41](/creator/twitter/planert41) | X | XXXXXX | X | XXXXX | | [@trentkelp](/creator/twitter/trentkelp) | X | XXXXX | X | XXXXX | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | X | XXXXX | X | XXXXX | | [@SamFazeli8](/creator/twitter/SamFazeli8) | XX | XXXXX | X | XXXXX | [View More](/list/creators/$smmt/100) ### Sentiment: XX% [#](/topic/$smmt/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% -X% **1 Month**: XX% +16% **6 Months**: XX% +5% **1 Year**: XX% +14% **1-Year High**: XXX% on 2025-10-06 **1-Year Low**: XX% on 2025-03-23 **Most Supportive Themes** - **Upcoming Phase X Data:** (40%) The anticipation of upcoming Phase X data fuels investor excitement. - **Bullish Sentiment and Recognition:** (30%) Positive mentions and recognition of Summit Therapeutics as a potential long-term holding boost investor confidence. - **Strategic Partnerships:** (10%) Strategic collaborations, such as the ADC combo deal with Pfizer, are viewed positively by investors. **Most Critical Themes** - **Competition Intensification:** (3%) Investors are concerned about increased competition in the PD-1/VEGF bispecific antibody market. - **Conflicting Macroeconomic Signals:** (2%) Uncertainty is introduced by conflicting macroeconomic signals. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXXX | XX% | XXXXXX | XX% | XXXXXX | XX% | | Reddit | XX | X% | XX | X% | X | X% | | YouTube | X | X% | X | X% | X | X% | | | | | | | | | | Total | XXXXXX | XX% | XXXXXX | XX% | XXXXXX | XX% | ### Social Dominance: XXXXX% [#](/topic/$smmt/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/social_dominance.tsv) **Current Value**: XXXXX% **Daily Average**: XXXXX% **1 Week**: XXXXX% +0.075% **1 Month**: XXXXX% +0.054% **6 Months**: XXXXX% -XXXX% **1 Year**: XXXXX% -XXXXX% **1-Year High**: XXXXX% on 2025-04-25 **1-Year Low**: XXXXXX% on 2025-10-07 ### Market Dominance: XXXXX% [#](/topic/$smmt/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/market_dominance.tsv) **Current Value**: XXXXX% **Daily Average**: X% **1-Year High**: XXXXX% on 2025-03-31 **1-Year Low**: XXXXX% on 2025-09-10 ### Market Cap: $XXXXXXXXXXXXXX [#](/topic/$smmt/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$smmt/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXXXXX **Daily Average**: $XXXXXXXXXXXXXX **1 Week**: $XXXXXXXXXXXXXX -$13% **1 Month**: $XXXXXXXXXXXXXX +$0.05% **6 Months**: $XXXXXXXXXXXXXX -$43% **1 Year**: $XXXXXXXXXXXXXX -$9.90% **1-Year High**: $XXXXXXXXXXXXXX on 2025-04-24 **1-Year Low**: $XXXXXXXXXXXXXX on 2025-04-08 **Top assets mentioned** In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours [Apple, Inc. (AAPL)](/topic/$aapl) [Netflix Inc (NFLX)](/topic/$nflx) [Johnson & Johnson (JNJ)](/topic/johnson-johnson) [Uber Technologies, Inc. (UBER)](/topic/$uber) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Lyft, Inc. Class A Common Stock (LYFT)](/topic/$lyft) [Nike Inc (NKE)](/topic/$nke) [Pfizer, Inc. (PFE)](/topic/$pfe) [NVIDIA Corp. (NVDA)](/topic/$nvda) **Top topics mentioned** In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours [$dcth](/topic/$dcth), [stocks technology](/topic/stocks-technology), [stocks healthcare](/topic/stocks-healthcare), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks communication services](/topic/stocks-communication-services), [stocks financial services](/topic/stocks-financial-services), [$aapl](/topic/$aapl), [stocks consumer defensive](/topic/stocks-consumer-defensive), [$nflx](/topic/$nflx), [$9926hk](/topic/$9926hk), [stocks basic materials](/topic/stocks-basic-materials), [stocks industrials](/topic/stocks-industrials), [johnson johnson](/topic/johnson-johnson), [$uber](/topic/$uber), [$mrk](/topic/$mrk), [$lyft](/topic/$lyft), [stocks](/topic/stocks), [$nke](/topic/$nke), [china](/topic/china), [coins made in usa](/topic/coins-made-in-usa), [$gsun](/topic/$gsun), [$pfe](/topic/$pfe), [$nvda](/topic/$nvda), [ibm](/topic/ibm), [tesla](/topic/tesla), [$clf](/topic/$clf), [$azn](/topic/$azn), [$qcom](/topic/$qcom), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [$bntx](/topic/$bntx), [$dx](/topic/$dx), [$dave](/topic/$dave), [stocks banks](/topic/stocks-banks), [$pep](/topic/$pep), [$mrna](/topic/$mrna), [$sbux](/topic/$sbux), [advanced micro devices](/topic/advanced-micro-devices), [$intc](/topic/$intc), [discord](/topic/discord), [$cat](/topic/$cat), [$wmt](/topic/$wmt), [$ma](/topic/$ma), [stocks energy](/topic/stocks-energy), [exxon mobil](/topic/exxon-mobil), [$mtc](/topic/$mtc), [$hd](/topic/$hd), [$ba](/topic/$ba), [$jnj](/topic/$jnj), [$tgt](/topic/$tgt), [about to](/topic/about-to), [$akesf](/topic/$akesf), [eli lilly](/topic/eli-lilly), [$hbt](/topic/$hbt), [walt disney](/topic/walt-disney), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$wfc](/topic/$wfc), [$gm](/topic/$gm), [warner bros discovery inc](/topic/warner-bros-discovery-inc), [costco](/topic/costco), [procter gamble](/topic/procter-gamble), [goldman sachs](/topic/goldman-sachs), [$amzn](/topic/$amzn), [$pypl](/topic/$pypl), [block inc](/topic/block-inc), [microsoft](/topic/microsoft), [iii](/topic/iii), [momentum](/topic/momentum), [$exel](/topic/$exel), [$lly](/topic/$lly), [$insm](/topic/$insm), [click the](/topic/click-the), [investment](/topic/investment), [$onc](/topic/$onc), [$bmy](/topic/$bmy), [$orcl](/topic/$orcl), [$bac](/topic/$bac), [$ibm](/topic/$ibm), [$gs](/topic/$gs), [$amd](/topic/$amd), [$sq](/topic/$sq), [morgan stanley](/topic/morgan-stanley), [manat](/topic/manat), [$cmnd](/topic/$cmnd), [coins defi](/topic/coins-defi), [$msft](/topic/$msft), [market cap](/topic/market-cap), [$til](/topic/$til), [$eose](/topic/$eose), [$ge](/topic/$ge), [miller](/topic/miller), [spikes](/topic/spikes), [$googl](/topic/$googl), [jpmorgan chase](/topic/jpmorgan-chase), [$cost](/topic/$cost), [protocol](/topic/protocol), [mcdonalds corp](/topic/mcdonalds-corp), [$xom](/topic/$xom), [jacob](/topic/jacob), [$mdgl](/topic/$mdgl), [united therapeutics corp](/topic/united-therapeutics-corp) ### Top Social Posts [#](/topic/$smmt/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$SMMT (-8.7% pre) Summit Therapeutics Shares Dip After Q3 Results Ivonescimab Strategy Moves Forward - msn" [X Link](https://x.com/OpenOutcrier/status/1980250481151606935) [@OpenOutcrier](/creator/x/OpenOutcrier) 2025-10-20T12:31Z 80.1K followers, 2121 engagements "**Summit Therapeutics Inc.** ($SMMT): SMMT Announces Positive Phase III Data Plans FDA Approval Filing" [Reddit Link](https://redd.it/1obh6hf) [@Educational_Cup9809](/creator/reddit/Educational_Cup9809) 2025-10-20T12:18Z X followers, X engagements "$SMMT plans to submit an application for approval of Ivonescimab to the FDA in Q4 - a very opportunistic approach in my opinion. Shares down X% pre-market. $MRK flat" [X Link](https://x.com/doepke_michel/status/1980235313235800146) [@doepke_michel](/creator/x/doepke_michel) 2025-10-20T11:31Z 5636 followers, 1357 engagements "Summit Therapeutics $SMMT Q3-25. Results: π Adj. EPS: -$0.13 π΄ π° Revenue: $X π΄ π Net Loss: $231.8M π Summit plans BLA submission for ivonescimab in Q4 2025 following strong Phase III HARMONi trial results" [X Link](https://x.com/Earnings_Time/status/1980233237701292045) [@Earnings_Time](/creator/x/Earnings_Time) 2025-10-20T11:22Z 12.3K followers, 1426 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Summit Therapeutics shares are up amid reports of a potential $15B licensing deal with AstraZeneca. Ivonescimab data disappoints in Western patients, causing concern.
Summit Therapeutics Inc. Common Stock (SMMT) is a biopharmaceutical company.
Summit Therapeutics Inc. Common Stock uses the ticker $SMMT for trading. Listed in the Stocks and category.
Price 24-Hour Time-Series Raw Data
The XXXX% price increase appears to be driven by positive market sentiment, hype from top creators, the anticipation of Phase X data, and a potential deal with AstraZeneca, fueled by rumors of a $XX billion partnership and increased social engagement.
24-Hour | 7-Day | 30-Day |
---|---|---|
-XXXX% | -XXXX% | XXXX% |
1-Year High: $XXXXX on 2025-04-24
1-Year Low: $XXXXX on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Summit Therapeutics Inc. Common Stock (SMMT) is currently AltRank #196 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX -XXX
1 Month: XXX -XXX
6 Months: XXX +155
1 Year: XXX -XX
1-Year High: XXXXX on 2025-08-11
1-Year Low: X on 2025-02-09
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +28
1 Month: XX +31
6 Months: XX -XX
1 Year: XX +4
1-Year High: XX on 2025-04-22
1-Year Low: X on 2025-03-18
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX +247%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +18%
1 Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-04-25
1-Year Low: XXX on 2025-09-20
Social Network | X | YouTube | |
---|---|---|---|
Engagements | XXXXXXX | XX | X |
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX -XXXX%
1 Year: XXXXXX +61%
1-Year High: XXX on 2025-07-18
1-Year Low: XX on 2025-10-07
Social Network | X | YouTube | |
---|---|---|---|
Mentions | XXX | X | X |
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Summit Therapeutics Inc. Common Stock (SMMT) in the last XX hours which is up XXX% from XX in the previous XX hours
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX +34%
1 Year: XXXXX +105%
1-Year High: XXX on 2025-07-18
1-Year Low: XX on 2025-10-07
The most influential creators that mention Summit Therapeutics Inc. Common Stock in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@Biotech2k1 | X | XXXXXX | X | XXXXXX |
@semodough | X | XXXXXX | X | XXXXXX |
@Banana_Oncology | X | XXXXX | X | XXXXXX |
@doepke_michel | X | XXXXX | X | XXXXX |
@JacobPlieth | X | XXXXXX | X | XXXXX |
@earnings_guy | X | XXXXXX | X | XXXXX |
@planert41 | X | XXXXXX | X | XXXXX |
@trentkelp | X | XXXXX | X | XXXXX |
@MarcJacksonLA | X | XXXXX | X | XXXXX |
@SamFazeli8 | XX | XXXXX | X | XXXXX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% +16%
6 Months: XX% +5%
1 Year: XX% +14%
1-Year High: XXX% on 2025-10-06
1-Year Low: XX% on 2025-03-23
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXXX | XX% | XXXXXX | XX% | XXXXXX | XX% |
XX | X% | XX | X% | X | X% | |
YouTube | X | X% | X | X% | X | X% |
Total | XXXXXX | XX% | XXXXXX | XX% | XXXXXX | XX% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.075%
1 Month: XXXXX% +0.054%
6 Months: XXXXX% -XXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-04-25
1-Year Low: XXXXXX% on 2025-10-07
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXXX% on 2025-09-10
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX -$13%
1 Month: $XXXXXXXXXXXXXX +$0.05%
6 Months: $XXXXXXXXXXXXXX -$43%
1 Year: $XXXXXXXXXXXXXX -$9.90%
1-Year High: $XXXXXXXXXXXXXX on 2025-04-24
1-Year Low: $XXXXXXXXXXXXXX on 2025-04-08
Top assets mentioned In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours
Apple, Inc. (AAPL) Netflix Inc (NFLX) Johnson & Johnson (JNJ) Uber Technologies, Inc. (UBER) Merck & Co., Inc. (MRK) Lyft, Inc. Class A Common Stock (LYFT) Nike Inc (NKE) Pfizer, Inc. (PFE) NVIDIA Corp. (NVDA)
Top topics mentioned In the posts about Summit Therapeutics Inc. Common Stock in the last XX hours
$dcth, stocks technology, stocks healthcare, stocks consumer cyclical, stocks communication services, stocks financial services, $aapl, stocks consumer defensive, $nflx, $9926hk, stocks basic materials, stocks industrials, johnson johnson, $uber, $mrk, $lyft, stocks, $nke, china, coins made in usa, $gsun, $pfe, $nvda, ibm, tesla, $clf, $azn, $qcom, stocks bitcoin treasuries, $bntx, $dx, $dave, stocks banks, $pep, $mrna, $sbux, advanced micro devices, $intc, discord, $cat, $wmt, $ma, stocks energy, exxon mobil, $mtc, $hd, $ba, $jnj, $tgt, about to, $akesf, eli lilly, $hbt, walt disney, coins solana ecosystem, $wfc, $gm, warner bros discovery inc, costco, procter gamble, goldman sachs, $amzn, $pypl, block inc, microsoft, iii, momentum, $exel, $lly, $insm, click the, investment, $onc, $bmy, $orcl, $bac, $ibm, $gs, $amd, $sq, morgan stanley, manat, $cmnd, coins defi, $msft, market cap, $til, $eose, $ge, miller, spikes, $googl, jpmorgan chase, $cost, protocol, mcdonalds corp, $xom, jacob, $mdgl, united therapeutics corp
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$SMMT (-8.7% pre) Summit Therapeutics Shares Dip After Q3 Results Ivonescimab Strategy Moves Forward - msn"
X Link @OpenOutcrier 2025-10-20T12:31Z 80.1K followers, 2121 engagements
"Summit Therapeutics Inc. ($SMMT): SMMT Announces Positive Phase III Data Plans FDA Approval Filing"
Reddit Link @Educational_Cup9809 2025-10-20T12:18Z X followers, X engagements
"$SMMT plans to submit an application for approval of Ivonescimab to the FDA in Q4 - a very opportunistic approach in my opinion. Shares down X% pre-market. $MRK flat"
X Link @doepke_michel 2025-10-20T11:31Z 5636 followers, 1357 engagements
"Summit Therapeutics $SMMT Q3-25. Results: π Adj. EPS: -$0.13 π΄ π° Revenue: $X π΄ π Net Loss: $231.8M π Summit plans BLA submission for ivonescimab in Q4 2025 following strong Phase III HARMONi trial results"
X Link @Earnings_Time 2025-10-20T11:22Z 12.3K followers, 1426 engagements
/topic/$smmt